Sixfold Bioscience

Developer of oligonucleotide delivery systems

placeLondon, England, United Kingdom calendar_todayFounded 2017 groups16 employees language sixfold.bio

Registered entities

Innovation

6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,464 times.

YearFilings
20191
20213
20223
20232
20242
20252
20261

Investor mix

6 investors on record; lead investors include Cantos Ventures, Y Combinator, Pi Campus, Lombardstreet Ventures.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%
Coming soon